Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         I, Fanjun Wu, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report of Sunwin International Neutraceuticals, Inc. on Form 10-QSB for the
period ended October 31, 2006 fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and that information
contained in such Quarterly Report on Form 10-QSB fairly presents in all
material respects the financial condition and results of operations of Sunwin
International Neutraceuticals, Inc.

December 15, 2006

                                               By:/s/ Fanjun Wu
                                               ---------------------------
                                               Fanjun Wu, CFO and Chief and
                                               Principal Accounting Officer





[A signed original of this written statement required by Section 906 has been
provided to Sunwin International Neutraceuticals, Inc. and will be retained by
Sunwin International Neutraceuticals, Inc. and furnished to the United States
Securities and Exchange Commission or its staff upon request.]